Theorem Appoints Biopharma Development EVP

Scott P. Treiber, Ph.D., has been appointed executive vice president and general manager at Theorem Clinical Research. Dr. Treiber will oversee all aspects of Theorem’s biopharmaceutical development, including early phase first-in-human and proof-of-concept studies and Phase II-IV studies across a wide range of therapeutic areas.
 
Previously, Dr. Treiber held executive positions within the CRO and pharma industries. Dr. Treiber is a founding member of the Clinical Research Exchange and is active in the Chicagoland Chapter of the Association of Clinical Research Professionals.
 
“Scott is an extraordinary individual with valuable experience in clinical development, medical affairs, data management and other areas of biopharmaceutical development,” said John Potthoff, Theorem president and chief executive officer. “He brings expertise in central nervous system, oncology, cardiology, infectious diseases, respiratory and other prime therapeutic areas. We couldn’t have asked for a more perfect fit.”